search for books and compare prices
MEDICAL / Psychiatry / Psychopharmacology matches 240 work(s)
at beginning |
displaying 1 to 25 |
next 25 >
show results in order: alphabetically | oldest to newest | newest to oldest
Paperback:
9783319329086 | 3 edition (Springer Verlag, July 12, 2016), cover price $109.00
Hardcover:
9783319339115 | Springer Verlag, October 6, 2016, cover price $209.00
Hardcover:
9783319341347 | Springer Verlag, November 4, 2016, cover price $209.00
Hardcover:
9781501105913 | Scribner, September 6, 2016, cover price $28.00
Hardcover:
9783319316871 | 2 edition (Springer Verlag, August 16, 2016), cover price $159.00
9783764385668 | 1 edition (Birkhauser, February 3, 2009), cover price $299.00
Hardcover:
9783319305943 | Springer Verlag, June 17, 2016, cover price $99.99
Hardcover:
9788132228011 | Springer Verlag, June 19, 2016, cover price $299.00
CD/Spoken Word:
9781522666509 | Mp3 una edition (Audible Studios on Brilliance audio, June 14, 2016), cover price $9.99
Paperback:
9781585625086 | 3 revised edition (Amer Psychiatric Pub Inc, June 9, 2016), cover price $97.00 | also contains What Your Patients Need to Know About Psychiatric Medications
9781585622030 | Spi pap/cd edition (Amer Psychiatric Pub Inc, April 1, 2005), cover price $79.00
Paperback:
9781585625086 | 3 revised edition (Amer Psychiatric Pub Inc, June 9, 2016), cover price $97.00 | also contains What Your Patients Need To Know About Psychiatric Medications
9781585623563 | 2 pap/cdr edition (Amer Psychiatric Pub Inc, April 27, 2009), cover price $100.00
Product Description: This book fills a significant research gap in how to integrate quality of life data into relevant clinical care plans, and to broaden its applicability to pharmacoeconomic studies of antipsychotic medications and health policy decision-making...read more
Hardcover:
9783319300597 | Adis, June 19, 2016, cover price $79.99 | About this edition: This book fills a significant research gap in how to integrate quality of life data into relevant clinical care plans, and to broaden its applicability to pharmacoeconomic studies of antipsychotic medications and health policy decision-making.
Product Description: Dieses Buch vermittelt einen umfassenden Ãberblick über das aktuelle Wissen auf dem Gebiet der Neuropsychopharmakologie im Kindes- und Jugendalter. Im ersten Teil werden die Grundlagen der Neuro-Psychopharmakologie dargelegt, um ein tieferes Verständnis der Therapieprinzipien sowie der Besonderheiten der Neuro-Psychopharmakologie bei Kindern und Jugendlichen zu erhalten...read more
Hardcover:
9783662486238 | 3 edition (Springer Verlag, June 12, 2016), cover price $129.00 | About this edition: Dieses Buch vermittelt einen umfassenden Ãberblick über das aktuelle Wissen auf dem Gebiet der Neuropsychopharmakologie im Kindes- und Jugendalter.
Hardcover:
9783319312125 | Springer Verlag, June 6, 2016, cover price $109.00
Hardcover:
9780231177306 | 1 edition (Columbia Univ Pr, April 26, 2016), cover price $35.00
Paperback:
9781908995186 | Muswell Pr, May 1, 2016, cover price $20.95 | About this edition: Essays on the role of psychedelics in culture and the treatment of mental illness.
Product Description: Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine...read more
Paperback:
9780198729471 | 2 edition (Oxford Univ Pr, May 24, 2016), cover price $59.95 | About this edition: Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia.
9780199586042 | 1 edition (Oxford Univ Pr, December 9, 2010), cover price $65.00 | About this edition: Antipsychotic long-acting injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia.
Product Description: Dementia is associated with a sizeable public health burden that is growing rapidly as the population ages. In addition to cognitive impairments, individuals with dementia often come to clinical attention because of symptoms of a behavioral disturbance (e...read more
Paperback:
9780890426777 | 1 edition (Amer Psychiatric Pub Inc, April 22, 2016), cover price $65.00 | About this edition: Dementia is associated with a sizeable public health burden that is growing rapidly as the population ages.
Hardcover:
9783319278810 | Adis, March 14, 2016, cover price $199.00
Hardcover:
9783319269337 | Springer Verlag, June 15, 2016, cover price $189.00
Hardcover:
9783319270388 | Adis, February 17, 2016, cover price $79.99
Hardcover:
9783319231495 | Springer Verlag, January 6, 2016, cover price $109.00
Product Description: This resource book concentrates on the most commonly used drugs, their side effects and properties, an introductory text for anyone studying drugs in the treatment of mental illness. The authors present a concise and easily accessible introduction to the nature and uses of psychiatric drugs, treatment, and the referral issues that could influence a counselors work with clients who are already using psychiatric medication or potentially should be...read more
Paperback:
9780534249601, titled "Counselor's Resource on Psychiatric Medications: Issues of Treatment and Referral" | Brooks/Cole Pub Co, January 1, 1995, cover price $30.95 | also contains Counselor''s Resource on Psychiatric Medications: Issues of Treatment and Referral | About this edition: This resource book concentrates on the most commonly used drugs, their side effects and properties, an introductory text for anyone studying drugs in the treatment of mental illness.
Product Description: In this book, the four leading experts on the ACE inhibitors donepezil, galantamine, and rivastigmine and the NMDA receptor antagonist memantine explain the practical pharmacology of these symptomatic drugs with the aim of providing a sound basis for their clinical use in patients with Alzheimerâs disease...read more
Hardcover:
9783319262048, titled "Practical Pharmacology for Alzheimerâs Disease" | Springer Verlag, February 19, 2016, cover price $129.00 | About this edition: In this book, the four leading experts on the ACE inhibitors donepezil, galantamine, and rivastigmine and the NMDA receptor antagonist memantine explain the practical pharmacology of these symptomatic drugs with the aim of providing a sound basis for their clinical use in patients with Alzheimerâs disease.
Psychopharmaka sind integraler Bestandteil einer differenzierten Therapie psychischer Erkrankungen. In der klinischen Praxis werden Patienten überwiegend mit einer Kombination mehrerer Psychopharmaka behandelt, auch wenn nur eine geringe Zahl kontrollierter Studien zur Effizienz von Kombinationsbehandlungen vorliegt. In diesem Buch werden alle verfügbaren Informationen zur Polypharmazie in der Behandlung psychischer Erkrankungen zusammengefasst und kritisch kommentiert. Die 2. Auflage wurde um Kapitel zu Interaktionen bei Polypharmazien ergänzt.
Hardcover:
9783709118481 | 3 edition (Springer Verlag, December 4, 2015), cover price $89.99
9783211798256 | 2 edition (Springer Verlag, August 26, 2009), cover price $59.99 | About this edition: Psychopharmaka sind integraler Bestandteil einer differenzierten Therapie psychischer Erkrankungen.
Product Description: The first authoritative textbook specifically addressing issues of the field, this book delivers a focused discussion on several themes in psychiatry while providing a sound background on pharmacovigilance. Internationally-recognised researchers, clinicians and pharmacovigilance experts contributed to this textbook, giving it the benefit of different perspectives and years of experience...read more
Hardcover:
9783319247397 | Adis, December 15, 2015, cover price $129.00 | About this edition: The first authoritative textbook specifically addressing issues of the field, this book delivers a focused discussion on several themes in psychiatry while providing a sound background on pharmacovigilance.
at beginning |
displaying 1 to 25 |
next 25 >